President of Vision Care Inc.
After she received her M.D. and Ph.D. from Kyoto University, Masayo Takahashi served as an assistant professor in the Kyoto University Hospital. She discovered the potential of stem cells as a tool for retina therapy when she moved to the Salk Institute, in the United States. She joined RIKEN in 2006, where her team launched a pilot clinical study using iPS cells first in human in 2013. She started a new career, as the president of a start up company; Vision Care Inc., to proceed and implement clinical therapy.